EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The HLA-II immunopeptidome of SARS-CoV-2

Shira Weingarten-Gabbay, Da-Yuan Chen, Siranush Sarkizova, Hannah B Taylor, Matteo Gentili, Gabrielle M Hernandez, Leah R Pearlman, Matthew R Bauer, Charles M Rice, Karl R Clauser, Nir Hacohen, Steven A Carr und 3 weitere

Cell Reports · 2024

DOI: 10.1016/j.celrep.2023.113596 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Shira Weingarten-Gabbay und 14 weiteren Autor:innen. Beteiligte Einrichtung: Broad Institute of MIT and Harvard University, Cambridge, MA, USA; Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, …. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansEpitopes, T-LymphocyteHistocompatibility Antigens Class IHLA AntigensHistocompatibility AntigensCD8-Positive T-LymphocytesPeptides

Stichwörter der Autor:innen

CD4(+) T cellCP: ImmunologyCP: MicrobiologyHLA-IISARS-CoV-2antigen processing and presentationimmunityimmunopeptidomenoncanonical proteinviral antigen

Substanzen

Epitopes, T-LymphocyteHistocompatibility Antigens Class IHLA AntigensHistocompatibility AntigensPeptides

Autor:innen und Institutionen

  • Broad Institute of MIT and Harvard University, Cambridge, MA, USA; Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA, USA; Laboratory of Virology and Infectious Disease, The Rockefelle…
  • Department of Biochemistry & Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
  • Broad Institute of MIT and Harvard University, Cambridge, MA, USA.
  • Harvard Program in Biological and Biomedical Sciences, Division of Medical Sciences, Harvard University Medical School, Boston, MA, USA.
  • Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.
  • Broad Institute of MIT and Harvard University, Cambridge, MA, USA; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Weingarten-Gabbay, S., Chen, D. Y., Sarkizova, S., Taylor, H. B., Gentili, M., Hernandez, G. M., Pearlman, L. R., Bauer, M. R., Rice, C. M., Clauser, K. R., Hacohen, N., Carr, S. A., Abelin, J. G., Saeed, M., & Sabeti, P. C. (2024). The HLA-II immunopeptidome of SARS-CoV-2. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113596

Vancouver

Weingarten-Gabbay S, Chen DY, Sarkizova S, Taylor HB, Gentili M, Hernandez GM, et al. The HLA-II immunopeptidome of SARS-CoV-2. Cell Reports. 2024. doi:10.1016/j.celrep.2023.113596

BibTeX
@article{WeingartenGabbay2024,
  author = {Weingarten-Gabbay, Shira and Chen, Da-Yuan and Sarkizova, Siranush and Taylor, Hannah B and Gentili, Matteo and Hernandez, Gabrielle M and Pearlman, Leah R and Bauer, Matthew R and Rice, Charles M and Clauser, Karl R and Hacohen, Nir and Carr, Steven A and Abelin, Jennifer G and Saeed, Mohsan and Sabeti, Pardis C},
  title = {The HLA-II immunopeptidome of SARS-CoV-2},
  journal = {Cell Reports},
  year = {2024},
  doi = {10.1016/j.celrep.2023.113596}
}
Kostenlos starten →